More Economical Use of Cyclosporine Through Combination Drug Therapy

2002 ◽  
Vol 38 (3) ◽  
pp. 205-208 ◽  
Author(s):  
Jenise C. Daigle

1999 ◽  
Vol 1 (1) ◽  
pp. 44-49 ◽  
Author(s):  
Khaldoon Alaswad ◽  
James H. O’Keefe ◽  
Richard M. Moe


2013 ◽  
Vol 64 (2) ◽  
pp. 228-243 ◽  
Author(s):  
Claudius Füllhase ◽  
Christopher Chapple ◽  
Jean-Nicolas Cornu ◽  
Cosimo De Nunzio ◽  
Christian Gratzke ◽  
...  


2000 ◽  
Vol 43 (11) ◽  
pp. 2397-2401 ◽  
Author(s):  
Marko H. Neva ◽  
Markku J. Kauppi ◽  
Hannu Kautiainen ◽  
Reijo Luukkainen ◽  
Pekka Hannonen ◽  
...  


PLoS ONE ◽  
2014 ◽  
Vol 9 (7) ◽  
pp. e101311 ◽  
Author(s):  
George L. Drusano ◽  
Michael Neely ◽  
Michael Van Guilder ◽  
Alan Schumitzky ◽  
David Brown ◽  
...  


1975 ◽  
Vol 15 (7) ◽  
pp. 511-517 ◽  
Author(s):  
WILLIAM E. THORNTON ◽  
BONNIE J. PRAY


Stroke ◽  
2003 ◽  
Vol 34 (9) ◽  
pp. 2246-2251 ◽  
Author(s):  
Stefan Zausinger ◽  
Karsten Schöller ◽  
Nikolaus Plesnila ◽  
Robert Schmid-Elsaesser


Author(s):  
Stephanie Mathieson ◽  
Richard Kasch ◽  
Christopher G Maher ◽  
Rafael Zambelli Pinto ◽  
Andrew J McLachlan ◽  
...  


2005 ◽  
Vol 40 (11) ◽  
pp. 954-962
Author(s):  
James M. Backes ◽  
Patricia A. Howard

This continuing feature will update readers on recent developments in cardiovascular pharmacotherapy. Cardiovascular disease remains the number one killer in the US, and more clinical outcome trials have been conducted in cardiology than in any other field of medicine. Given this rapidly expanding knowledge base, pharmacists can have a significant impact on prevention and treatment — if they keep current with developments in drug therapy.



Sign in / Sign up

Export Citation Format

Share Document